Retrospective Review of Symptomatic Intracranial Hemorrhage (ICH) in Cancer Patients Treated with Bevacizumab; the Memorial Sloan-Kettering (MSK) Experience
conference contribution
posted on 2010-03-02, 00:00authored byMustafa Khasraw, Samuel A Goldlust, Andrew B Lassman, Lisa M DeAngelis
Retrospective Review of Symptomatic Intracranial Hemorrhage (ICH) in Cancer Patients Treated with Bevacizumab; the Memorial Sloan-Kettering (MSK) Experience